HanAll Signs Exclusive Licensing Agreement with Turn Biotechnologies
28 May 2024 //
CONTRACT PHARMA
HanAll Biopharma: Turn Bio Deal For Novel Eye, Ear Disease Treatments
28 May 2024 //
PR NEWSWIRE
Turn Biotechnologies Shows Promise Epigenetic Reprogramming to Rejuvenate Skin
01 May 2023 //
PR NEWSWIRE
Turn Bio to Present at the Guggenheim Healthcare Talks
04 Apr 2023 //
PR NEWSWIRE